Latest share price

Current

697.60p

Average

-12.30p LSE

-1.73% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

11/02/2019

Notice of Preliminary Results

Read more

07/02/2019

Oxford Biomedica provides update on programmes outlicensed to Sanofi

Read more

06/12/2018

Oxford Biomedica notes Axovant announcement of feedback from FDA regarding AXO-...

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo